Understanding immune patterns and ECMO strategies to help adults with severe ARDS
Official title: Mechanistic Investigation of Inflammatory and Immune Dysregulation in Moderate-to-Severe ARDS and Rescue Strategies With Extracorporeal Membrane Oxygenation
Run by Southeast University, China · NCT07726940 · Data updated 2026-11-12
This study tests how different immune and clinical patterns in adults with moderate-to-severe ARDS respond to ECMO and lung-protective care, aiming to improve outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1776 (estimated) |
| Sponsor | Southeast University, China Academic / other |
| Locations | 39 sites (Beijing, Beijing Municipality and 38 other locations) |
| Status | Recruiting |
| Started | June 16, 2026 |
| Main results expected | January 2030 |
| Study ends | February 2030 |
| Registry record updated | July 27, 2026 |
| Trial ID | NCT07726940 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age 18 and older) with moderate-to-severe ARDS as defined by current criteria and meeting eligibility for the study.
✕Probably not a fit
Patients with conditions that preclude ECMO or who do not fit the defined ARDS phenotype classifications may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project seeks to classify moderate-to-severe ARDS patients into distinct immune- and clinical-based phenotypes and identify targeted therapeutic approaches for each. It investigates molecular mechanisms behind ECMO-related complications and how immune biomarkers relate to benefits from awake ECMO. The study also aims to define a precision intervention pathway for ECMO management across the patient journey, using data collected from multiple Chinese centers. By examining heterogeneity in ARDS and the immune response during ECMO, the research intends to inform more effective, individualized management strategies. Overall, the work addresses high mortality and resource use in ARDS by seeking to tailor ECMO and ventilation approaches to patient-specific biology.
Why it matters
Potential benefit: If successful, patients with moderate-to-severe ARDS could see improved survival and fewer complications through more personalized ECMO and ventilation strategies.
How similar studies have gone: Previous work in ARDS and ECMO has shown that phenotype-based approaches can guide therapy, but this specific immune-phenotype and awake-ECMO biomarker strategy is innovative and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1.Age ≥ 18 years 2.Meet the global new definition of moderate-to-severe Acute Respiratory Distress Syndrome (ARDS). Exclusion Criteria: \- 1.Patients with a prior tracheostomy. 2.Patients who have received a lung transplant or initiated VV-ECMO support as a bridge to lung transplantation. 3.Patients with comorbid cardiogenic shock requiring VA-ECMO or VAV-ECMO support.
Where it's running
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting -
Fujian Provincial Hospital
Fuzhou, Fujian, China Recruiting -
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, China Recruiting -
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting -
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China Recruiting -
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Show 33 more locations
-
The First People's Hospital of Chenzhou
Chenzhou, China Recruiting -
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China Recruiting -
The Second Affiliated Hospital of Harbin Medical University
Ha’erbin, China Recruiting -
Liuzhou People's Hospital
Liuzhou, China Recruiting -
Nanjing Drum Tower Hospital
Nanjing, China Recruiting -
Quzhou People's Hospital
Quzhou, China Recruiting -
Wuxi People's Hospital
Wuxi, China Recruiting -
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China Recruiting -
Henan Provincial People's Hospital
Zhengzhou, China Recruiting -
Zhongshan Hospital of Traditional Chinese Medicine
Zhongshan, China Recruiting -
The Second Hospital of Jilin University
Changchun, China Not yet recruiting -
The Second Affiliated Hospital of Dalian Medical University
Dalian, China Not yet recruiting -
Hangzhou First People's Hospital, Westlake University School of Medicine
Hangzhou, China Not yet recruiting -
The First Affiliated Hospital of Harbin Medical University
Ha’erbin, China Not yet recruiting -
Huai'an First People's Hospital
Huai'an, China Not yet recruiting -
Kunshan First People's Hospital
Kunshan, China Not yet recruiting -
The First Hospital of Lanzhou University
Lanzhou, China Not yet recruiting -
The First People's Hospital of Lianyungang
Lianyungang, China Not yet recruiting -
People's Hospital of Guangxi Zhuang Autonomous Region
Naning, China Not yet recruiting -
Jiangsu Province Hospital
Nanjing, China Not yet recruiting -
The First Affiliated Hospital of Guangxi Medical University
Nanning, China Not yet recruiting -
The Second Affiliated Hospital of Guangxi Medical University
Nanning, China Not yet recruiting -
Affiliated Hospital of Nantong University
Nantong, China Not yet recruiting -
General Hospital of Ningxia Medical University
Ningxiang, China Not yet recruiting -
West China Tianfu Hospital, Sichuan University
Sichuan, China Not yet recruiting -
Suining Central Hospital
Suining, China Not yet recruiting -
The First Affiliated Hospital of Soochow University
Suzhou, China Not yet recruiting -
The First Affiliated Hospital of Xiamen University
Xiamen, China Not yet recruiting -
Affiliated Hospital of Qinghai University
Xining, China Not yet recruiting -
Xinyang Central Hospital
Xinyang, China Not yet recruiting -
Affiliated Hospital of Xuzhou Medical University
Xuzhou, China Not yet recruiting -
Subei People's Hospital
Yangzhou, China Not yet recruiting -
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China Not yet recruiting
Study contacts
- Study coordinator: yingzi Huang Yingzi,Huang
- Email: yz_huang@126.com
- Phone: 18271428804
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimal corticosteroid dosing for ARDS: short vs. prolonged therapy
This trial tests different corticosteroid doses and treatment lengths to see which helps adults with ARDS who are on ventilators.
-
Lateral positioning to optimize breathing in adults after abdominal surgery with ARDS
This study tests whether lying on the left or right side helps improve lung function in adults who developed ARDS after abdominal surgery, using a bedside imaging test to watch ventilation and blood flow while changing positions.
-
Dexamethasone for sepsis-related ARDS in adults on ventilatory support
This trial tests whether dexamethasone can help adults with sepsis-associated ARDS on ventilators recover better compared to placebo.
-
NIRS for EDResp: Which first helps hypoxemic adults best?
This trial tests whether non-invasive ventilation with a mask (NIPPV) or high-flow nasal oxygen (HFNO) is more helpful for adults in the emergency department with acute hypoxemic respiratory failure.
-
Sodium bicarbonate with bedside electrical impedance tomography to map lung blood flow in ventilated adults
This project will try whether a small sodium bicarbonate injection combined with bedside electrical impedance tomography can map lung blood flow in adults on mechanical ventilation, compared with hypertonic saline.
-
How torso tilt and ventilator PEEP affect lung opening in ARDS
This study will see if tilting the patient's torso and changing PEEP helps open more lung and improve breathing mechanics in adults with moderate to severe ARDS on a ventilator.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.